New Frontiers in Cancer 2003 Detection and Diagnosis

描述（由申请人提供）：早期癌症的准确检测对于通过开发癌症特异性干预措施以避免侵袭、转移性传播和随后的晚期疾病来改善患者护理至关重要。 国家癌症研究所的癌症预防部门已经建立了早期检测研究网络（EDRN），这是一个多机构联盟，致力于改进在最早期检测癌症的方法。 EDRN已经发展成为一个国际研究计划，支持和促进广泛的研究活动，特别是开发和验证用于准确检测早期癌症的分子和遗传工具以及初级预防方法。 拥有尖端技术的多学科专家正在共同努力，以实现改善患者护理的使命。 戈登癌症检测和诊断新前沿会议的目的是将具有基础，转化和临床肿瘤学专业知识的初级和高级医生和科学家以及计算地质学，生物技术和信息学方面的专家聚集在一起，形成有利于建立伙伴关系的独特培育环境。 这样的设置提供了一个独特的机会和场所，激烈的讨论和癌症研究的评估，建立研究重点的优点，并通过新建立的合作领域的进步。 在专注于联合生物学，肿瘤学和技术的氛围中，医生和科学家将有机会合作开发临床应用，以改善患者护理。

DESCRIPTION (provided by applicant): The accurate detection of early stage cancer is critical to improve patient care by developing cancer specific interventions to avert invasion, metastatic dissemination and subsequent advanced disease. The National Cancer Institute's Division of Cancer Prevention has established the Early Detection Research Network (EDRN), a multi-institutional consortium endeavoring to improve methods for detecting cancer at its earliest state. The EDRN has developed into an international research program of substantial charge and scope that supports and facilitates a broad spectrum of research activities, particularly the development and validation of molecular and genetic tools for the accurate detection of early stage cancer as well as methods for primary prevention. Armed with cutting-edge technology, multidisciplinary experts are working together to fulfill the mission of improving patient care. The purpose of the Gordon Conference on New Frontiers in Cancer Detection and Diagnosis is to bring together junior and senior physicians and scientists with expertise in basic, translational and clinical oncology, was well as experts in computational geology, biotechnology and informatics in a unique nurturing environment conducive to forging partnerships. Such a setting provides a unique opportunity and venue for intense discussion and evaluation of cancer research, establishing the merit of research priorities, and advancement of the field through newly established collaborations. In an atmosphere focused on uniting biology, oncology and technology, physicians and scientists will have an opportunity to collaboratively develop clinical applications to improvement of patient care.